GSK3B and Alzheimer disease: It is widely known that GSK-3β is inhibited via phosphorylation at specific serine residues (e.g., serine 9 for GSK-3β) [33], and accumulation of active GSK-3β has been implicated in neurofibrillary degeneration in AD [42].